CClinicalTrials.gg
RecruitingNCT07822971SIMRéaUpdated Sep 24, 2026

Impact of an On-site Simulation-based Training Programme on Adherence to Standard Precautions and Healthcare-associated Infections in Adult Intensive Care

An observational study in Cross Infection, sponsored by Centre Hospitalier Régional Metz-Thionville. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Centre Hospitalier Régional Metz-Thionville · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, single-centre, quasi-experimental before-and-after study conducted over 18 months in an adult ICU. The study includes a 6-month pre-intervention period, a 6-month intervention period during which healthcare professionals participate in repeated in situ simulation sessions, and a 6-month post-intervention period.

Read the detailed description

Healthcare-associated infections (HAIs) remain a major patient safety concern in intensive care units (ICUs), despite the widespread availability of evidence-based infection prevention and control (IPC) recommendations. Standard precautions (SPs) are the cornerstone of IPC, yet their implementation remains inconsistent in routine clinical practice. Beyond knowledge and technical proficiency, maintaining reliable implementation of standard precautions in ICUs requires healthcare professionals to manage interruptions, cognitive workload, competing priorities and teamwork in a complex clinical environment.

SIMREA is an implementation strategy based on in situ simulation, designed to strengthen three complementary competencies required for the reliable implementation of standard precautions: knowledge, technical skills and non-technical skills. Simulation scenarios reproduce routine ICU situations and integrate contextual challenges encountered in daily practice, allowing healthcare professionals to apply infection prevention measures under realistic working conditions.

02

Conditions studied

  • Cross Infection

Browse trials for

Keywords

  • Cross Infection
  • Infection Control
  • Universal Precautions
  • Intensive Care Units
  • Simulation Training
  • Patient Safety
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients hospitalized in the adult intensive care unit at CHR Metz-Thionville during the study period

Inclusion criteria

  • Patients hospitalized in the adult intensive care unit at CHR Metz-Thionville during the study period
  • Patients aged 18 years or older
  • Patients with a length of stay in the intensive care unit of 48 hours or more
  • Patients for whom the data necessary to assess the outcome measures are available in the electronic health record and/or hospital surveillance databases
  • Patients who have been informed about the use of their health data for research purposes, in accordance with the procedures established by the institution

Exclusion criteria

Exclusion Criteria:

  • Patients who, after being informed, objected to the use of their health data for this research
04

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Phase I : Pre-intervention period

    Baseline period for data collection prior to the implementation of the SimRéa programme

    Other: No intervention

  • Phase II : Intervention period

    Gradual roll-out of the SimRéa training programme to resuscitation professionals: doctors, nurses and nursing assistants.

    Other: Simulation-based training programme

  • Phase III : Post-intervention period

    An evaluation period designed to measure the impact of the intervention following the end of its roll-out.

    Other: No intervention

Interventions

  • OtherSimulation-based training programme

    SimRéa programme is based on low-fidelity simulation scenarios that replicate common resuscitation situations, deliberately incorporating human factors that may affect the application of standard precautions (task interruptions, cognitive load, interprofessional demands). Data collection

  • OtherNo intervention

    Data Collection

05

What researchers measure

Primary outcomes

  1. Change in the incidence density of intensive care unit-acquired healthcare-associated infections between the pre-intervention and post-intervention periods

    The primary outcome will be the incidence density of healthcare-associated infections acquired in the intensive care unit, expressed as the number of infections per 1,000 patient-days. An infection will be considered ICU-acquired if it meets the CTINILS 2007 diagnostic criteria and occurs at least 48 hours after admission to the intensive care unit. The infections under surveillance will include, in particular, healthcare-associated pneumonia, bloodstream infection, and healthcare-associated urinary tract infection. The incidence density will be calculated as follows: Number of ICU-acquired healthcare-associated infections / Total number of patient-days × 1,000

    Time frame: Continuously assessed throughout the 18-month study period (Months 1-18), with the primary analysis comparing the pre-intervention period (Months 1-6) and the post-intervention period (Months 13-18)

Secondary outcomes

  1. Change in alcohol-based hand rub consumption between the pre-intervention and post-intervention periods

    Alcohol-based hand rub consumption will be assessed using the French ICSHA (Hydroalcoholic Solution Consumption Index) indicator and expressed as the percentage achievement of the standardized national consumption target. Monthly ICSHA values will be compared between the pre-intervention and post-intervention periods

    Time frame: Assessed monthly throughout the 18-month study period (Months 1-18). The primary analysis will compare the pre-intervention (Months 1-6) and post-intervention (Months 13-18) periods

  2. Change in hand hygiene compliance between the pre-intervention and post-intervention periods

    Hand hygiene compliance will be assessed through direct observation using the standardized Hand Hygiene Australia observation tool, based on the World Health Organization's "My 5 Moments for Hand Hygiene" framework. Compliance will be expressed as: Number of compliant hand hygiene actions / Total number of observed hand hygiene opportunities × 100

    Time frame: Assessed monthly throughout the 18-month study period (Months 1-18). The primary analysis will compare the pre-intervention (Months 1-6) and post-intervention (Months 13-18) periods

  3. Association between cumulative SimRéa training coverage and changes in infection prevention indicators

    The cumulative proportion of trained healthcare professionals will be calculated monthly as: Number of eligible healthcare professionals who have attended at least one SimRéa training session / Total number of eligible healthcare professionals in the unit × 100. The cumulative training coverage will be examined in relation to the following monthly indicators: a) hand hygiene compliance rate \[% : Number of compliant opportunities / Total number of opportunities observed × 100\] ; b) alcohol-based hand rub consumption measured using the ICSHA indicator \[% : Percentage of achievement of the standardised national target for the use of hydroalcoholic solutions\] ; c) incidence density \[Number\] of ICU-acquired healthcare-associated infections, expressed per 1,000 patient-days. This exploratory analysis will assess the presence of an organisational dose-response relationship between increasing training coverage and changes in infection prevention outcomes

    Time frame: From the beginning to the end of the study period (month 1 to month 18)

06

Study locations

1 of 1 sites recruiting
  • CHR Metz-Thionville, Hôpital de Mercy
    Metz, 57085, France
    • Mathieu LLORENS, MD · Principal investigator
    • Olfa EZZI, MD · Sub investigator
    Recruiting
07

Registry details

Key details

Study ID
NCT07822971
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Responsible party
Sponsor
First posted
Sep 16, 2026
Start date
Mar 1, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Mar 2028 (estimated)
Last update
Sep 24, 2026

Study contacts

Mélanie JUNKE
Contact
projet-recherche-clinique@chr-metz-thionville.fr
0033387179886
Arpiné EL NAR, PhD
Contact
projet-recherche-clinique@chr-metz-thionville.fr
0033387557766
Dr. Mathieu LLORENS, MD
principal investigator · CHR Metz-Thionville, Hôpital de Mercy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion